Startseite
Podcasts
The Daily Podcast
The Sunday Read: ‘Ozempic Could Crush the Junk Food Industry. But It Is Fighting Back.’

The Sunday Read: ‘Ozempic Could Crush the Junk Food Industry. But It Is Fighting Back.’

The Daily vor 1 Jahr

0:00

28:06

For decades, Big Food has been marketing products to people who
can’t seem to stop eating, and now, suddenly, they can. The
active ingredient in new drugs like Ozempic, Wegovy and Zepbound
mimics a natural hormone that slows digestion and signals
fullness to the brain.

Around seven million Americans take these drugs, but estimates
from Morgan Stanley suggest that number could increase to 24
million within the next decade. More than 100 million American
adults are obese, and the drugs may eventually be rolled out to
people who don’t have diabetes or obesity, as they seem to tame
addictions beyond food — appearing to make cocaine, alcohol and
cigarettes more resistible. Research is at an early stage, but
the drugs may also cut the risk of stroke, heart and kidney
disease, Alzheimer’s and Parkinson’s.

Major food companies are scrambling to research the impact of the
drugs on their brands — and figure out how to adjust. But for
Mattson, which has invented products for the nation’s biggest
food conglomerates for nearly 50 years, the Ozempic threat could
be a boon.

Subscribe today at nytimes.com/podcasts or on Apple Podcasts and
Spotify. You can also subscribe via your favorite podcast app
here
https://www.nytimes.com/activate-access/audio?source=podcatcher.
For more podcasts and narrated articles, download The New York
Times app at nytimes.com/app.

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for
information about our collection and use of personal data for
advertising.